Access To Medicine Foundation
  • Who we are
  • What we do
  • Impact
  • Insights & resources
  • News & events
  • Donate
Donate

Who we are

An independent non-profit organisation accelerating progress toward global health equity.

  • About us
  • How we drive change
  • Our strategy 2022 - 2026
  • Governance
  • Team
  • Funders
  • Annual reports

What we do

We catalyse progress toward equitable access to essential medicines in low- and middle-income countries through our work across diverse research areas.

  • R&D-based pharma companies
  • Medical gas companies
  • Generic medicine manufacturers
  • Diagnostics companies
  • Vaccine manufacturers
  • Antimicrobial resistance
  • Diabetes care

Impact

Discover how our work drives real-world progress on access to medicine.

  • Our achievements
  • Voices of our community
  • How we drive change
  • Partner with us

Insights & resources

Discover our evidence-based research, insights and other changemaking tools.

  • Research hub
  • Company profiles & report cards
  • Access insights
  • The Health Equity podcast
  • Health Equity through Her Lens

News & events

Stay informed on our latest events, collaborations, engagements, and Foundation news.

  • News
  • Events & engagements
  • In the media

Follow us

Often searched

Index ranking

Vacancies

10 year analysis

Follow us

  • About us
  • How we drive change
  • Our strategy 2022 - 2026
  • Governance
  • Team
  • Funders
  • Annual reports
  • R&D-based pharma companies
  • Medical gas companies
  • Generic medicine manufacturers
  • Diagnostics companies
  • Vaccine manufacturers
  • Antimicrobial resistance
  • Diabetes care
  • Our achievements
  • Voices of our community
  • How we drive change
  • Partner with us
  • Research hub
  • Company profiles & report cards
  • Access insights
  • The Health Equity podcast
  • Health Equity through Her Lens
  • News
  • Events & engagements
  • In the media

Gabrielle Breugelmans presents the AMR Benchmark at World AMR Congress in Washington, DC

On 26 October, Gabrielle Breugelmans, Director of Research of the Access to Medicine Foundation, will join the World Antimicrobial Resistance Congress in Washington, DC. 

Date

26 October 2018

About Gabrielle Breugelmans

Gabrielle Breugelmans is responsible for the direction and delivery of the Foundation’s research programmes and other research activities. She is an infectious disease epidemiologist with broad expertise in global health, poverty-related diseases and vaccinology in low- to middle-income countries. She holds a PhD and Master of Public Health degree in Epidemiology from the Johns Hopkins Bloomberg School of Public Health in the U.S., and a Master’s degree in Health Sciences from the University of Maastricht in the Netherlands.

Gabrielle will give a presentation on stewardship best practices drawing from the findings of the Antimicrobial Resistance Benchmark, which is the first independent assessment of pharma company action on antimicrobial resistance, covering antimicrobial R&D, responsible production and appropriate access and stewardship.

Access to Medicine Foundation

Subscribe to our newsletter

Vacancies FAQs Contact us

Follow us

Access to Medicine Foundation is funded by

Terms & conditions Privacy & cookie policy Disclaimer

Copyright 2004 - 2026 Access to Medicine Foundation - All Rights Reserved